Prescription Required.
Degarelix (the active ingredient)Other inactive ingredients (specifics vary by formulation – check your medication's packaging)
Treatment of advanced prostate cancer
Management of hormonesensitive prostate cancer
Degapride 120mg Inj (Degarelix) is a gonadotropin-releasing hormone (GnRH) antagonist. It works by blocking the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland. This leads to a decrease in testosterone production, which is crucial in the growth of prostate cancer cells.
Store Degarelix at controlled room temperature (20°C to 25°C), away from direct sunlight and moisture. Keep out of reach of children. Dispose of used needles and syringes properly.
Dosage varies depending on the individual and the specific condition being treated. Consult your doctor for accurate dosing instructions.
It is usually administered as a subcutaneous injection (under the skin).
Follow your doctor's instructions precisely regarding injection sites and techniques.
Hot flashes
Decreased libido (sex drive)
Impotence (erectile dysfunction)
Gynecomastia (breast enlargement in men)
Increased risk of osteoporosis
Nausea
Fatigue
Moderate alcohol consumption should be discussed with your doctor; excessive alcohol use is not advised.
Degarelix may cause dizziness or fatigue. Avoid driving or operating machinery if affected.
Degarelix is not indicated for use in pregnant or breastfeeding women. Inform your doctor if you are pregnant or plan to become pregnant.
Degarelix is not indicated for use in children.
Renal impairment may necessitate dose adjustment. Your physician will consider your kidney function before and during treatment.
Hepatic impairment may necessitate dose adjustment. Your physician will consider your liver function before and during treatment.
Consult your doctor or pharmacist for complete prescribing information and a detailed patient information leaflet.
Product monograph of Degarelix
